What Does Pharma 4.0 Mean to Cell and Gene Therapy Drug Manufacturers?

By Kelly Stewart

Pharma 4.0 is the convergence of people, systems, and data within one singular network, creating a new era of digital transformation powered by advanced technologies such as artificial intelligence (AI) and machine learning. By collecting and analyzing data, investing in the right technologies, and developing the necessary skills and expertise, Pharma 4.0 can help CGT companies identify potential risks and take steps to mitigate them. CGT companies also need to develop the skills and expertise necessary to use these technologies effectively to reap the rewards. Find out about the benefits of Pharma 4.0 along with some challenges that need to be addressed.